# A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

> **NCT03367390** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 30 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DEVICE:** AID System
- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT03367390
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-08
- **Primary completion:** 2018-02-09
- **Final completion:** 2018-02-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367390, "A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03367390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*